BioSpace News Archive

Mr. Dickinson joined Gilead in 2016 and has transformed the way that the company approaches corporate development, expanding the kinds of transactions executed and implementing a broader and more strategic approach to deal-making.

About 66% of women blame themselves for losing a pregnancy, and almost half were advised erroneously by doctor to wait a few cycles before trying to conceive again

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, today announced the addition of Scott Applebaum to its team as lead strategic regulatory consultant.

Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the development of genetic and molecular diagnostics and companion therapeutics, announces that it has engaged CLSA Capital Markets Limited, a CITIC Securities Company, to provide introductions to potential strategic partners and regulatory guidance to support the launch of its proprietary genetic-based products into China’s (PRC) rapidly growing markets for women’s health and fertility.

CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present at the 2019 BIO Investor Forum, which is being held October 22-23 at the Westin St. Francis Hotel in San Francisco, CA.

Systech, a global technology leader in digital brand protection and product authentication, today announced a new release of the Systech Brand Protection Suite™—its fully integrated platform to combat counterfeiters, solve product diversion and meet regulatory compliance.

Amgen (NASDAQ:AMGN) today announced the expansion of Myeloma MVP™, a national initiative to help myeloma patients and their care teams create their Most Valuable Plan.

Endocrinologists play crucial role in prevention, diagnosis and management of osteoporosis

New health plan offerings include comprehensive dental coverage, a health and wellness allowance and more

In late 2018, Robert Ruffini, President of Fluxtrol Inc., and Producer / Writer / Digital Strategist, Stephen Sadler, started discussing a project with a simple goal in mind - to create a unique way to tell Fluxtrol’s story.